Question 20544 — diseases

Summary

Ms. Blandine Brocard draws the attention of the Minister of Solidarity and Health to the situation of patients suffering from peritoneal carcinomatosis, a rare cancer affecting less than 250 new cases each year in France. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CCR/HIPEC) can cure or prolong the survival of these patients. The closure in November 2018 of the hospital care center Lariboisière, which carried out more than 120 CHIP per year, required the transfer of its activity to other centers which drastically limit the number of annual treatments due to the non-coverage of CHIP by the CPAM and a financial loss for the establishments of 15 to 20,000 euros per treatment. She therefore questions her about the solutions she could provide to resolve this problem and in particular about the possibility, Like most European countries, treatment of HIPEC, included for more than fifteen years in the CPAM nomenclature, for these rare cancers which have no other validated treatment.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

• Blandine Brocard · auteur

Related records

No cross-record relationships stored yet.